Read + Share
Amedeo Smart
Independent Medical Education
Zhou C, Dong X, Chen G, Wang Z, et al. Atezolizumab plus bevacizumab and chemotherapy in metastatic nonsquamous NSCLC: the randomized double-blind phase 3 IMpower151 trial. Nat Med 2025;31:2375-2384.PMID: 40379995
Email
LinkedIn
Privacy Policy